Extubate with Confidence.

Successful extubation can be facilitated using the Vapotherm Hi-VNI Technology. 

Request an On-Site Demonstration

Collins CL, et al. J. Pediatrics. 2013 162(5): 949-54.

Reduce Nasal Trauma with Vapotherm

CPAP interfaces have been shown to cause significantly higher incidence rate of nasal trauma than Vapotherm. Damage to the nasal mucosa may be a cause of unexplained septicemia in the preterm population. Nosocomial sepsis places a significant burden on the infant, family, clinicians and health care system. On average, preventing each incident of nosocomial sepsis will reduce length of stay by 5.2 days and save an institution $10,000.1

1 Collins CL, Holberton JR, Barfield C & Davis PG. A Randomized Controlled Trial to Compare Heated Humidified High-Flow Nasal Cannula with Nasal Continuous Positive Airway Pressure Postextubation in Premature Infants. J. Pediatr. 2013 162(5): 949-54.

Similar Safety to CPAP

The 2016 Cochrane Review concludes HFNC is similar in clinical efficacy and safety to all other forms of NIV with significantly less nasal trauma and potentially less pneumothorax.1

Reduce BPD

Vapotherm can be a tool for early extubation that, in conjunction with other clinical care practices, may reduce BPD.2

1 Wilkinson D, Andersen C, O’Donnell CPF, De Paoli AG, Manley BJ. High flow nasal cannula for respiratory support in preterm infants. Cochrane Database of Systematic Reviews 2016, Issue 2. Art. No.: CD006405. DOI: 10.1002/14651858.CD006405.pub3
2 M. Robbins, J. Trittmann, E. Martin, K.M. Reber, L. Nelin*, E. Shepherd. Early extubation attempts reduce length of stay in extremely preterm infants even if re-intubation is necessary. JNPM 2015; Volume 8, Number 2.